Noel Donnelly

Direttore Finanziario/CFO presso PEPGEN INC.

Patrimonio netto: - $ in data 31/05/2024

54 anni

Consumer Services

Health Technology

Posizioni attive di Noel Donnelly

Società	Posizione	Inizio	Fine
PEPGEN INC.	Direttore Finanziario/CFO	01/10/2021	-

Società	Posizione	Inizio	Fine
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	Direttore Finanziario/CFO	01/07/2019	01/10/2021

Babson College	Masters Business Admin
University of Massachusetts Lowell	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Consumer Services	3
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
PEPGEN INC.	Health Technology

Aziende private	1
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology